Concepedia

Publication | Open Access

Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial

60

Citations

32

References

2024

Year

References

YearCitations

Page 1